Tag: Cancer: Lung
More African-Americans Screened for Lung Cancer With USPSTF 2021 Criteria
Expanding lung cancer screening criteria is step toward greater equity for high-risk populations
Income, Education Linked to Advanced Stage of Diagnosis of NSCLC
Findings persist among race/ethnic groups, regardless of government or private insurance, and across facility types
ASCO: Ramucirumab Plus Pembrolizumab Promising in NSCLC
In phase 2 trial, overall survival longer with combo treatment compared with investigator's choice for standard of care in advanced NSCLC
Outcomes Seem No Worse With Stereotactic RT for Brain Mets in SCLC
Survival outcomes for SCLC patients with brain metastases appear to be equitable with stereotactic radiosurgery, whole brain radiotherapy
Follow-Up Often Delayed After High-Risk Findings on Lung Cancer Screening
Patients with more severe findings less likely to have prolonged delays; current smokers had more delays than former smokers
Slight Increase Reported in Lung Cancer, Brain Tumors With Wildfire Exposure
Individuals exposed to wildfire within 50 km of residential locations in past 10 years had slightly higher incidence
Number of Mesothelioma Deaths Up Among Women From 1999 to 2020
However, age-adjusted death rate per 1 million women decreased significantly, from 4.83 to 4.15 from 1999 to 2020
Emphysema on CT Linked to Increased Risk for Lung Cancer
Pooled odds ratios for lung cancer increased with emphysema severity, and were higher for visual versus quantitative assessments on chest CT
AACR: Adding Nivolumab to Neoadjuvant Chemo Slows Resectable NSCLC
Event-free survival prolonged and percentage of patients with a pathological complete response higher with addition of nivolumab
Stage Shift Seen With CT Screening for Lung Cancer in the U.S.
Stage shift toward Stage I NSCLC observed following introduction of low-dose CT screening for lung cancer